Literature DB >> 12027437

Definition of regulatory network elements for T cell development by perturbation analysis with PU.1 and GATA-3.

Michele K Anderson1, Gabriela Hernandez-Hoyos, Christopher J Dionne, Alexandra M Arias, Dan Chen, Ellen V Rothenberg.   

Abstract

PU.1 and GATA-3 are transcription factors that are required for development of T cell progenitors from the earliest stages. Neither one is a simple positive regulator for T lineage specification, however. When expressed at elevated levels at early stages of T cell development, each of these transcription factors blocks T cell development within a different, characteristic time window, with GATA-3 overexpression initially inhibiting at an earlier stage than PU.1. These perturbations are each associated with a distinct spectrum of changes in the regulation of genes needed for T cell development. Both transcription factors can interfere with expression of the Rag-1 and Rag-2 recombinases, while GATA-3 notably blocks PU.1 and IL-7Ralpha expression, and PU.1 reduces expression of HES-1 and c-Myb. A first-draft assembly of the regulatory targets of these two factors is presented as a provisional gene network. The target genes identified here provide insight into the basis of the effects of GATA-3 or PU.1 overexpression and into the regulatory changes that distinguish the developmental time windows for these effects. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027437     DOI: 10.1006/dbio.2002.0674

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  37 in total

Review 1.  Transcriptional control of thymocyte positive selection.

Authors:  Gilbert J Kersh
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  HEB-deficient T-cell precursors lose T-cell potential and adopt an alternative pathway of differentiation.

Authors:  Marsela Braunstein; Michele K Anderson
Journal:  Mol Cell Biol       Date:  2010-12-28       Impact factor: 4.272

3.  Epithelial lineages of the small intestine have unique patterns of GATA expression.

Authors:  Mary R Dusing; Dan A Wiginton
Journal:  J Mol Histol       Date:  2005-02       Impact factor: 2.611

4.  Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling.

Authors:  Tom N Taghon; Elizabeth-Sharon David; Juan Carlos Zúñiga-Pflücker; Ellen V Rothenberg
Journal:  Genes Dev       Date:  2005-04-15       Impact factor: 11.361

Review 5.  Progression of regulatory gene expression states in fetal and adult pro-T-cell development.

Authors:  Elizabeth-Sharon David-Fung; Mary A Yui; Marissa Morales; Hua Wang; Tom Taghon; Rochelle A Diamond; Ellen V Rothenberg
Journal:  Immunol Rev       Date:  2006-02       Impact factor: 12.988

6.  Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3.

Authors:  Tom Taghon; Mary A Yui; Ellen V Rothenberg
Journal:  Nat Immunol       Date:  2007-07-01       Impact factor: 25.606

7.  A gene regulatory network armature for T lymphocyte specification.

Authors:  Constantin Georgescu; William J R Longabaugh; Deirdre D Scripture-Adams; Elizabeth-Sharon David-Fung; Mary A Yui; Mark A Zarnegar; Hamid Bolouri; Ellen V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-22       Impact factor: 11.205

8.  Id1 attenuates Notch signaling and impairs T-cell commitment by elevating Deltex1 expression.

Authors:  Hong-Cheng Wang; S Scott Perry; Xiao-Hong Sun
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 9.  Eliciting the T cell fate with Notch.

Authors:  Dil Afroz Sultana; J Jeremiah Bell; Daniel A Zlotoff; Maria Elena De Obaldia; Avinash Bhandoola
Journal:  Semin Immunol       Date:  2010-06-02       Impact factor: 11.130

10.  GATA-3 is required for early T lineage progenitor development.

Authors:  Tomonori Hosoya; Takashi Kuroha; Takashi Moriguchi; Dustin Cummings; Ivan Maillard; Kim-Chew Lim; James Douglas Engel
Journal:  J Exp Med       Date:  2009-11-23       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.